证券代码：301448 证券简称：开创电气 浙江开创电气股份有限公司 编号：2025-006 投资者关系活动记录表 | | 配件建设的，暂时不能全部覆盖对美客户订单。 | | --- | --- | | | 三、公司对美订单，相关产品核心零部件是在越南基地生 | | | 产吗？核心零部件放在越南基地生产的考量是什么？ | | | 是的。电机和注塑件都是在越南生产，因为按照美国海关 | | | 要求，从越南出口到美国的产品必须要有原产地证明，所以我 | | | 们将核心部件放在越南生产。 | | | 四、越南生产基地是否享受相关优惠政策？ | | | 企业所得税前 4 年度享受免税政策，后续 9 年减免 50%。 | | | 五、公司对美业务占比是多少？ | | | 美国系公司的重要海外市场之一，具体业务情况可关注公 | | | 司相关公告。 | | | 六、越南基地第二期预计什么时候建设？ | | | 视客户订单情况建设。 | | | 七、截至目前，越南生产基地的人员数量大概多少？产能 | | | 利用率多少？ | | | 越南生产基地员工数量 月份刚刚量产，目 160 人左右，6 | | | 前产能在爬坡阶 ...

重要内容提示： ● 投资标的名称：印尼孙公司（尚未成立），公司名称以当地相关部门最终注册核准的名称为准，以下 简称"印尼孙公司"。 ● 交易简要内容：广州维力医疗器械股份有限公司(以下简称"公司")拟通过全资子公司WELL LEAD GLOBAL LIMITED（維力環球有限公司）作为出资主体，与公司董事长、实际控制人向彬先生共同投 资设立印尼孙公司，并投资建设印尼生产基地，项目总投资500亿印尼盾（折合人民币约2,000万人民 币，实际投资金额以相关主管部门批准金额为准），其中維力環球有限公司出资475亿印尼盾，持股 95%，向彬出资25亿印尼盾，持股5%。 ● 本次对外投资涉及与公司董事长、实际控制人向彬先生共同投资，构成关联交易，但不构成《上市公 司重大资产重组管理办法》规定的重大资产重组。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 ● 本事项已经公司第五届董事会第十五次会议审议通过，关联董事向彬已回避表决，无需提交公司股东 大会审议。 ● 相关风险提示：本次投资尚需履行国内境外投资备案手续或审批，以及印尼当地投资 ...

证券代码：300879 证券简称：大叶股份 宁波大叶园林设备股份有限公司 投资者关系活动记录表 编号：2025-002 投资者关系活动类别 √特定对象调研 □ 分析师会议 □ 媒体采访 □ 业绩说明会 □ 新闻发布会 □ 路演活动 □ 现场参观 □ 其他 （电话会议） 参与单位名称及 人员姓名 财通证券：于健 浦泓投资：彭聪 华安基金：孔涛 博道基金：吴子卓 时间 2025 年 5 月 14 日 (周三) 上午 10:30-12:00 地点 浙江省余姚市锦凤路 58 号三楼会议室 上市公司接待人员姓名 董事长、总经理 叶晓波 董事会秘书 吴军 财务负责人 吴伯凡 证券事务代表 王俊男 投资者关系活动主要 内容介绍 风险提示：本次调研信息中如涉及对外部环境判断、公司发展战略、未来计划等描 述，不构成公司对投资者的实质承诺，投资者及相关人士均应对此保持足够的风险 认识。敬请广大投资者理性投资，注意投资风险。 一、投资者提问及回复 1、美国与墨西哥之间有没有关税？ 答：目前根据《美墨加协定》要求以及相关政策和法律规定，公司产品不加征关税。 2、新收购的 AL-KO 公司的基本情况？ 答：AL-KO 公司是一家欧洲知 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company reported a revenue of 4.749 billion yuan in 2024, representing a year-on-year growth of 34.22%, while the net profit attributable to the parent company was 296 million yuan, a slight decline of 0.56% year-on-year. In Q4 2024, the revenue reached a historical high of 1.359 billion yuan, with a year-on-year increase of 30.94%, but the net profit decreased by 17.67% year-on-year. In Q1 2025, the revenue was 1.01 billion yuan, up 17.93% year-on-year, and the net profit increased by 34.81% year-on-year [3][4] Summary by Sections Financial Performance - In 2024, the company achieved revenues of 4.749 billion yuan, with a year-on-year growth of 34.22%. The net profit attributable to the parent company was 296 million yuan, down 0.56% year-on-year. The Q4 2024 revenue was 1.359 billion yuan, up 30.94% year-on-year, while the net profit was 71 million yuan, down 17.67% year-on-year. For Q1 2025, the revenue was 1.01 billion yuan, up 17.93% year-on-year, and the net profit was 58 million yuan, up 34.81% year-on-year [3][4] Sales Growth - The company experienced sustained high demand with new customers, channels, and projects accelerating. In 2024, the revenue from various product lines included office chairs (3.416 billion yuan), sofas (645 million yuan), massage chairs (240 million yuan), and others, showing significant year-on-year growth rates [4] Strategic Investments - The company is strategically investing in building its own brand and developing new businesses, which has temporarily impacted the net profit margin. The gross margin for 2024 was 21.64%, down 1.24 percentage points year-on-year. The net profit margin was 6.24%, down 2.18 percentage points year-on-year [5] International Expansion - The company has established two overseas production bases in Vietnam and Romania, enhancing its competitive advantage. The Vietnam base has been operational since 2018, while the Romania base began production in 2023, supporting the company's ability to meet global customer demands [6][7] Future Outlook - The company is transitioning from a primarily export-oriented model to a balanced approach of domestic and international sales, along with a focus on its own brand. Revenue projections for 2025-2027 are 5.625 billion yuan, 6.425 billion yuan, and 7.116 billion yuan, respectively, with corresponding net profits of 363 million yuan, 439 million yuan, and 518 million yuan [8][10]